Abstract:BACKGROUND: Long-noncoding RNAs (lncRNAs) could exert a crucial effect on the development of human cancers, including CRC. However, the biological function and underlying mechanism of LINCRNA00460 in the development of CRC still need deeper exploration.MATERIALS AND METHODS: The expression of LINC00460 in CRC tissues and cell lines was assessed by qRT-PCR. Cell proliferation, migration, and invasion were measured by the respective cell counting Kit-8 (CCK-8), wound healing assay and transwell invasion assay. Cell apoptosis and caspase-3 activity were detected by flow cytometry and caspase-3 activity assay. The relationship between LINC00460 and miR-613 expression was explored by Dual-luciferase reporter assay. Protein expression was measured by Western blotting. In vivo tumour growth was evaluated using a xenograft model of nude mice.RESULTS: LINC00460 was markedly up-regulated in CRC tissues and cell lines compared to their corresponding controls, which was closely correlated with clinical stage, TNM (T) classification, nodal (N) classification, metastasis (M) classification, liver metastasis and pathological differentiation, and survival rate of CRC patients. Functionally, LINC00460 knockdown decreased the proliferative, migrative and invasive abilities, and enhanced apoptosis rates and caspase-3 activity in HT29 and LOVO cells. Mechanistic studies indicated that miR-613 was targeted by LINC00460, and SphK1 was targeted and inversely regulated by miR-613 in HT29 and LOVO cells. In vivo studies, LINC00460 knockdown attenuated tumour growth. MiR-613 downregulation and SphK1 upregulation in the CRC tissues, and LINC00460 expression levels were inversely correlated with miR-613 expression and positively correlated with the SphK1 mRNA expression. Overall, LINC00460 modulated cell proliferation, migration, invasion and sphingosine kinase 1 (SphK1) expression in HT29 and LOVO cells, at least in most part, by regulating miR-613.CONCLUSION: LINC00460 functions as a competing endogenous RNA to regulate SphK1 expression by sponging miR-613 in CRC and provides a valuable therapeutic strategy for CRC patients.

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn's Disease.

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn’s Disease

Lncrnacnn3-206 Activates Intestinal Epithelial Cell Apoptosis and Invasion by Sponging Mir-212, an Implication for Crohn's Disease

Abstract 991: Long Non-Coding RNA LINC01133 Inhibits Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

Sa1730 Gastric Cancer Related Lncrna-Mtm Involved in Cell Migration and Invasion by Interacting with MT1F

LINCRNA01094 Promotes Renal Interstitial Fibrosis via the Mir-513b-5p/MELK/Smad3 Axis

TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2–SAMD2–SMAD3 Axis

Long Non-Coding RNA LINC01133 Inhibits Epithelial–mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

Expression Alteration of Long Non-Coding RNAs and Their Target Genes in the Intestinal Mucosa of Patients with Crohn’s Disease

LINC00958 Promotes Endometrial Cancer Cell Proliferation and Metastasis by Regulating the Mir-145-3p/tcf4 Axis.

LncRNA MSC-AS1 Regulates SNIP1 SUMOylation-mediated EMT by Binding to SENP1 to Promote Intestinal Fibrosis in Crohn's Disease.

Long Intergenic Non-Coding RNA LINC00485 Exerts Tumor-Suppressive Activity by Regulating Mir-581/Edem1 Axis in Colorectal Cancer.

LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition

Long Noncoding RNA LINC01296 Induces Non-Small Cell Lung Cancer Growth and Progression Through Sponging Mir-5095

Role of LINC01592 in TGF-β1-induced Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells

LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages

LINC01123 Promotes Progression of Colorectal Cancer Via Mir-625-5p/lasp1 Axis

LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis

LINC00511 Promotes Lung Squamous Cell Carcinoma Proliferation and Migration Via Inhibiting Mir-150-5p and Activating TADA1

The role of long non-coding RNA in Crohn's disease

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613